The rates of mortality for each race/ethnicity over time are shown using spline lines.
The rate of morbidities for each race/ethnicity over time are shown using spline lines. BPD indicates bronchopulmonary dysplasia; ICH/PVL, intracranial hemorrhage/periventricular leukomalacia; LOS, late-onset sepsis; NEC, necrotizing enterocolitis; NDI, neurodevelopmental impairment; ROP, retinopathy of prematurity.
eTable 1. Selected Antenatal and Postnatal Treatments by Race/Ethnicity
eTable 2. Comparison of Effect Sizes for Differences in Type 3 P Values Between Different Models
eFigure 1. Adjusted Mortality Rate Over Time by Race/Ethnicity (2002-2016) Comparing Black With White Infants and Hispanic With White Infants
eFigure 2. Mortality by Race/Ethnicity Over Time (2002-2016) Excluding 1321 Infants (529 Black, 452 White, and 340 Hispanic) Who Died Within 12 Hours Without Delivery Room Resuscitation
eFigure 3. Selected Postnatal and Antenatal Care Practices by Race/Ethnicity Over Time
eFigure 4. Adjusted Odds Ratios and 95% Confidence Intervals Comparing Mortality for Black vs White Infants and Hispanic vs White Infants at Each of the 25 Centers That Participated
Customize your JAMA Network experience by selecting one or more topics from the list below.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Travers CP, Carlo WA, McDonald SA, et al. Racial/Ethnic Disparities Among Extremely Preterm Infants in the United States From 2002 to 2016. JAMA Netw Open. 2020;3(6):e206757. doi:10.1001/jamanetworkopen.2020.6757
Are racial/ethnic disparities in care practices and major outcomes increasing or decreasing among extremely preterm infants in the US?
In this cohort study of 20 092 extremely preterm infants, racial/ethnic disparities in rates of antenatal corticosteroids and cesarean delivery decreased over time. Changes in rates of mortality and most major morbidities did not differ among white, black, and Hispanic infants, and while mortality decreased over time from 2002 to 2016, rates of moderate-severe neurodevelopmental impairment increased over time in all groups.
Racial/ethnic disparities in rates of potentially life-saving care practices decreased over time in the US, with reductions in mortality but increases in neurodevelopmental impairment in all racial/ethnic groups.
Racial/ethnic disparities in quality of care among extremely preterm infants are associated with adverse outcomes.
To assess whether racial/ethnic disparities in major outcomes and key care practices were changing over time among extremely preterm infants.
Design, Setting, and Participants
This observational cohort study used prospectively collected data from 25 US academic medical centers. Participants included 20 092 infants of 22 to 27 weeks’ gestation with a birth weight of 401 to 1500 g born at centers participating in the National Institute of Child Health and Human Development Neonatal Research Network from 2002 to 2016. Of these infants, 9316 born from 2006 to 2014 were eligible for follow-up at 18 to 26 months’ postmenstrual age (excluding 5871 infants born before 2006, 2594 infants born after 2014, and 2311 ineligible infants including 64 with birth weight >1000 g and 2247 infants with gestational age >26 6/7 weeks), of whom 745 (8.0%) did not have known follow-up outcomes at 18 to 26 months.
Main Outcomes and Measures
Rates of mortality, major morbidities, and care practice use over time were evaluated using models adjusted for baseline characteristics, center, and birth year. Data analyses were conducted from 2018 to 2019.
In total, 20 092 infants with a mean (SD) gestational age of 25.1 (1.5) weeks met the inclusion criteria and were available for the primary outcome: 8331 (41.5%) black infants, 3701 (18.4%) Hispanic infants, and 8060 (40.1%) white infants. Hospital mortality decreased over time in all groups. The rate of improvement in hospital mortality over time did not differ among black and Hispanic infants compared with white infants (black infants went from 35% to 24%, Hispanic infants went from 32% to 27%, and white infants went from 30% to 22%; P = .59 for race × year interaction). The rates of late-onset sepsis among black infants (went from 37% to 24%) and Hispanic infants (went from 45% to 23%) were initially higher than for white infants (went from 36% to 25%) but decreased more rapidly and converged during the most recent years (P = .02 for race × year interaction). Changes in rates of other major morbidities did not differ by race/ethnicity. Death before follow-up decreased over time (from 2006 to 2014: black infants, 14%; Hispanic infants, 39%, white infants, 15%), but moderate-severe neurodevelopmental impairment increased over time in all racial/ethnic groups (increase from 2006 to 2014: black infants, 70%; Hispanic infants, 123%; white infants, 130%). Rates of antenatal corticosteroid exposure (black infants went from 72% to 90%, Hispanic infants went from 73% to 83%, and white infants went from 86% to 90%; P = .01 for race × year interaction) and of cesarean delivery (black infants went from 45% to 59%, Hispanic infants went from 49% to 59%, and white infants went from 62% to 63%; P = .03 for race × year interaction) were initially lower among black and Hispanic infants compared with white infants, but these differences decreased over time.
Conclusions and Relevance
Among extremely preterm infants, improvements in adjusted rates of mortality and most major morbidities did not differ by race/ethnicity, but rates of neurodevelopmental impairment increased in all groups. There were narrowing racial/ethnic disparities in important care practices, including the use of antenatal corticosteroids and cesarean delivery.
Mortality and morbidity rates among extremely preterm infants are decreasing,1 but few studies have focused on changes in major outcomes, including neurodevelopmental impairment, by race/ethnicity over time. Published reports document higher infant mortality rates among black infants in the United States,2 largely driven by a higher rate of preterm delivery.3,4 Although black mothers are more likely to deliver preterm and low-birth-weight infants,5-7 a survival advantage among black preterm infants and low-birth-weight infants has been reported.8 However, data from national population-based data sets have shown that the mortality rate among very preterm black infants is higher than that among very preterm white infants or among Hispanic infants,4 while the infant mortality rate may be decreasing faster among white infants and Hispanic infants relative to black infants.2,9
Racial disparities in health outcomes between white perterm infants and black preterm infants may be due to differences in care practices,10-12 but vital statistics databases do not collect this information.13,14 In addition to mortality and major morbidities, including neurodevelopmental impairment, data on selected prenatal and postnatal care practices are included in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network database. The primary goal of the present study was to assess whether racial/ethnic differences in hospital mortality rates were changing over time among infants born at one of the centers in this network. We also assessed whether racial/ethnic differences in rates of major morbidities and in utilization rates of major prenatal and postnatal care practices were changing over time.
This cohort study evaluated maternal and neonatal data collected prospectively by trained research personnel. We included infants from 22 0/7 through 27 6/7 weeks’ gestation and with a birth weight 401 g to 1500 g born at one of the centers in the National Institute of Child Health and Human Development Neonatal Research Network between January 1, 2002, and December 31, 2016. Infants with congenital anomalies who were not resuscitated and infants who were stillborn were excluded. Infants without anomalies who died during the first 12 hours after birth with or without resuscitation15 were included. Gestational age was determined by best obstetrical estimate when available; otherwise, the best neonatal estimate was used.15 We followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline. Data collection was approved by each center’s institutional review board. Most centers approved a waiver of informed consent (45 CFR part 46). Otherwise, written informed consent was obtained in a manner consistent with the US Common Rule requirements. No one received compensation or was offered any incentive for participating in this study.
Self-reported maternal race/ethnicity was abstracted from the medical record and used to define infant race/ethnicity. Mothers with more than 1 race, unknown race/ethnicity, or race/ethnicity other than black non-Hispanic (referred to as black in the present study), white non-Hispanic (referred to as white in the present study), or Hispanic (including black or white) were not included. Paternal race/ethnicity was not recorded. Hospital outcomes until death, hospital discharge, or 120 days were collected using standardized definitions.1 Bronchopulmonary dysplasia was defined as the use of supplemental oxygen at 36 weeks’ postmenstrual age. Severe intracranial hemorrhage was defined as ventricular enlargement with concurrent or prior blood in the ventricles, or parenchymal blood or echodensity or both. Proven necrotizing enterocolitis was defined as stage 2 or greater by the modified Bell criteria.16 Severe retinopathy of prematurity was defined as stage 3 or greater or receiving surgery or both. Moderate-severe neurodevelopmental impairment at 18 to 26 months corrected age was defined as moderate or severe cerebral palsy based on an abnormal neuromotor examination and a score higher than 2 on the Gross Motor Function Classification System scale17; bilateral blindness; bilateral hearing loss receiving amplification; or cognitive composite score less than 70 on Bayley Scales of Infant Development, Third Edition (Bayley-III). Infants were eligible for follow-up if they weighed 401 to 1000 g from 2006 to 2007 regardless of gestational age, if they had a gestational age from 22 0/7 to 26 6/7 weeks from 2008 to 2014 regardless of weight, or if they were in a clinical trial that assessed neurodevelopmental outcomes. For uniformity, neurodevelopmental outcomes were not analyzed for infants born before 2006 because the Bayley-III was introduced in that year.18 Antenatal care practices examined included exposure to antibiotics in the 72 hours before delivery, any antenatal corticosteroids, or magnesium sulfate, and mode of delivery. Postnatal care practices included treatment with surfactant, mechanical ventilation, or postnatal steroids for bronchopulmonary dysplasia, and whether any human milk was received in the first 28 days after birth.
The primary outcome was the difference between black infants, Hispanic infants, and white infants (the reference group) in the rate of change of the in-hospital mortality rate over time. Prespecified exploratory outcomes included changes in rates of major morbidities and receipt of care practices over time. Because mortality is a competing outcome for major morbidities in extremely preterm infants, composite rates of mortality or individual major morbidities were also evaluated.19 An a priori power calculation showed that the sample of all infants delivered between 2002 and 2016 would provide more than 90% power to detect a statistically significant odds ratio of 0.9 or lower or 1.1 or higher (corresponding to the primary analysis of the interaction term between race and time for in-hospital mortality), assuming a 2-sided statistical significance level of 5%.
Unadjusted differences in categorical variables were analyzed with the χ2 test. The Kruskal-Wallis test was used for continuous skewed variables. Logistic regression was performed adjusting for infant and maternal factors present at birth associated with adverse infant outcomes, including infant gestational age, birth weight, sex, antenatal corticosteroid exposure, mode of delivery, multiple gestation, small for gestational age (<10th centile),20 birth center, and prenatal care, and maternal age, educational level, insurance status, marital status, diabetes (pregestational and gestational), hypertension (chronic and pregnancy-induced), and antepartum hemorrhage. Missing data were not imputed. All models were adjusted for birth year (numerical variable) and tested for the presence of statistical interaction between birth year and race/ethnicity. A type 3 P value for the interaction term between race/ethnicity and time was used to evaluate whether adjusted rates of change over time for a given outcome differed by race/ethnicity. Smoothed lines were fit to the unadjusted data using a spline routine. Smoothing splines provide a flexible means for smoothing noisy data using piecewise polynomial regression modeling to uncover patterns in the data.
Post hoc logistic regression models adjusting for biological variables alone (gestational age, birth weight, sex, multiple gestation, small for gestational age, maternal diabetes, maternal hypertension, and antepartum hemorrhage), care practice variables alone (antenatal corticosteroid exposure, mode of delivery, center, and prenatal care), and socioeconomic factors alone (insurance status, maternal educational level, maternal age, and marital status) were undertaken to understand the relative association of these factors with the complete model. We conducted additional sensitivity analyses excluding maternal educational level owing to a high rate of missing data (15.9%). Sensitivity analyses were also undertaken excluding infants who died within 12 hours after birth without resuscitation to ensure that results were not affected by postnatal restriction of care and also excluding centers that were not part of the Neonatal Research Network for the entire period to examine for confounding by center participation. Differential associations of race/ethnicity by center were also explored by adding an interaction term between race/ethnicity and center.21 We used SAS software, version 9.4 (SAS Institute Inc), for statistical analyses, with a 2-sided P < .05 indicating statistical significance. Analyses were conducted from 2018 to 2019.
In total, 20 092 infants with a mean (SD) gestational age of 25.1 (1.5) weeks met the inclusion criteria and were available for the primary outcome: 8331 (41.5%) black infants, 3701 (18.4%) Hispanic infants, and 8060 (40.1%) white infants. Baseline maternal characteristics, including rates of documented chorioamnionitis, hypertension, antepartum hemorrhage, prenatal care, high school graduation, private health insurance, and marriage differed by race/ethnicity (Table 1). Black infants had lower mean (SD) birth weight compared with white infants (754  vs 790  g), whereas there was no difference in birth weights between Hispanic infants (785  g) and white infants. White infants (32.2%) were more likely to be from multiple birth pregnancies compared with black infants (21.0%) or with Hispanic infants (19.6%). Of 9316 infants eligible for follow-up based on birth year, birth weight, and gestational age (excluded 5871 infants born before 2006, 2594 infants born after 2014, and 2311 ineligible infants including 64 with birth weight above 1000 g and 2247 infants with gestational age above 26 6/7 weeks), 749 (8.0%) did not have known follow-up outcomes at 18 to 26 months. Missing follow-up outcome data did not vary significantly by race/ethnicity (303 black infants [40.5%], 123 Hispanic infants [16.4%], and 323 white infants [43.1%]).
There was no statistically significant interaction of race by year in the adjusted rate of improved in-hospital mortality among black infants or Hispanic infants compared with white infants (P = .59 for race × year interaction) (Table 2; Figure 1). From 2002 to 2016, the unadjusted hospital mortality rate decreased from 35% to 24% among black infants, from 32% to 27% among Hispanic infants, and from 30% to 22% among white infants (Table 2; Figure 1). After adjustment for baseline characteristics, the hospital mortality rate decreased from 16% (95% CI, 13%-18%) to 12% (95% CI, 11%-15%) among black infants, from 17% (95% CI, 14%-21%) to 13% (95% CI, 11%-16%) among Hispanic infants, and from 21% (95% CI, 19%-24%) to 15% (95% CI, 13%-18%) among white infants (eFigure 1 in the Supplement). Black infants had significantly lower adjusted mortality rates compared with white infants from 2002 to 2011 (eFigure 1 in the Supplement). There was no significant difference in adjusted mortality rates between Hispanic and white infants for any study year.
There were 1321 infants who died within 12 hours without resuscitation. The racial/ethnic distribution was 529 of 8331 black infants (6.3%), 340 of 3701 Hispanic infants (9.2%), and 452 of 8060 white infants (5.6%) (P < .001). After exclusion of these infants, there remained no difference in the rate of improvement in hospital mortality among black infants (went from 27% to 21%) and Hispanic infants (went from 25% to 20%) compared with white infants (went from 27% to 18%) over time (P = .44, for race × year interaction) (Table 2; eFigure 2 in the Supplement). Among those eligible for follow-up at 22 to 26 months, mortality decreased over time across all groups, and there was a significant race × year interaction (P = .02) due to a faster decrease among Hispanic infants (went from 47% to 28%) compared with white infants (went from 39% to 33%) during this shortened period (Table 2).
For composite outcomes, there was a significant race × year interaction in the rate of late-onset sepsis or death because the rates among black infants (went from 59% to 40%) and Hispanic infants (went from 62% to 42%) were initially higher but decreased faster compared with white infants (went from 54% to 40%) and converged during the most recent years (P = .04; Table 2). Race × year interactions were not found for other composite outcomes, including moderate-severe neurodevelopmental impairment or death; bronchopulmonary dysplasia or death; severe intracranial hemorrhage or periventricular leukomalacia or death; proven necrotizing enterocolitis or death; and severe retinopathy of prematurity or death.
For individual morbidity outcomes, there was a significant race × year interaction in the rate of late-onset sepsis because the rates among black infants (went from 37% to 24%) and Hispanic infants (went from 45% to 23%) were initially higher but decreased faster compared with white infants (went from 36% to 25%) and converged during the most recent years (P = .02) (Table 3; Figure 2). Race × year interactions were not found for other morbidity outcomes, including moderate-severe neurodevelopmental impairment, bronchopulmonary dysplasia, severe intracranial hemorrhage or periventricular leukomalacia, proven necrotizing enterocolitis, and severe retinopathy of prematurity. Rates of moderate-severe neurodevelopmental impairment increased over time across all groups (increase from 2006 to 2014: black infants, 70%; Hispanic infants, 123%; white infants, 130%).
There was a significant race × year interaction for exposure to any antenatal corticosteroids because the rate was initially lower among black infants (went from 72% to 90%) and Hispanic infants (went from 73% to 83%), but this difference with white infants (went from 86% to 90%) decreased over time (P = .01 for race × year interaction) (eTable 1 and eFigure 3 in the Supplement). Differences in cesarean delivery narrowed significantly over time as the rate increased among black and Hispanic infants compared with white infants (P = .03 for race × year interaction). Increasing rates of antibiotic exposure within 72 hours before delivery were observed in all groups but increased faster among Hispanic infants (P = .01 for race × year interaction). There was no difference in the rate of treatment with magnesium sulfate before delivery by race/ethnicity. The rate of treatment with mechanical ventilation decreased across all groups over time, and there was a significant race × year interaction because rates of treatment decreased faster among Hispanic infants (black infants went from 91% to 88%, Hispanic infants went from 95% to 83%, and white infants 94% to 90%; P = .02 for race × year interaction) (eTable 1 and eFigure 3 in the Supplement). There was no significant race × year interaction for treatment with surfactant or postnatal corticosteroids for bronchopulmonary dysplasia or for breast milk exposure in the first 28 days after birth.
Center participation was examined as a potential confounder in an analysis restricted to 11 centers that participated for the entire study period, and the results for mortality over time did not differ (P = .79 for race × year interaction). To better understand center differences by race/ethnicity, we then dropped the race × year interaction term and added a term for race × center interaction to allow for race/ethnicity associations to differ by center. This interaction was statistically significant (P < .001). However, further analyses showed that this race × center interaction was mostly due to differences in magnitude rather than to the direction of the association because the trend toward lower adjusted mortality rates among minority infants was generally consistent (eFigure 4 in the Supplement). There was a high degree of collinearity between race/ethnicity and differences in socioeconomic factors, perinatal care practices, and biological factors, which made it difficult to determine the relative contribution of each variable to any differences in outcomes (eTable 2 in the Supplement). Sensitivity analyses excluding maternal educational level did not significantly alter our results.
This large multicenter cohort study showed no racial/ethnic disparities in changes over time in mortality or most major neonatal morbidities among extremely preterm infants. While hospital mortality decreased over time, rates of moderate-severe neurodevelopmental impairment increased across all racial/ethnic groups. Racial/ethnic disparities in late-onset sepsis narrowed over time, decreasing faster among black infants and Hispanic infants compared with white infants before converging. Racial/ethnic disparities in the rates of important care practices, including receipt of antenatal corticosteroids and cesarean delivery, also decreased over time among black infants and Hispanic infants compared with white infants.
Population-based data sets comparing survival trends have noted a narrowing survival advantage among extremely preterm and extremely low-birth-weight black infants compared with white infants,22-24 and 1 study found that mortality increased among very low-birth-weight black infants and was associated with a survival disadvantage.25 Recent data from the Vermont Oxford Network noted a narrowing survival disadvantage among black and among Hispanic very preterm infants.12 The aforementioned studies did not adjust for many known risk factors for adverse outcomes, including biological, care practice, and socioeconomic variables.26 In the present study, in contrast to the unadjusted mortality rates, adjusted mortality rates favored black infants and Hispanic infants compared with white infants.
Exclusion of infants who died without resuscitation did not alter our results, suggesting that mortality rates by race/ethnicity were not significantly associated with postnatal restriction of care. However, a larger proportion of Hispanic infants died without resuscitation. Differences in hospital rates of active treatment account for a large proportion of variation in survival among periviable infants, and these rates vary by race/ethnicity.21 Socioeconomic factors are associated with lower rates of survival within 1 hour after birth among periviable infants, likely owing to differences in providing resuscitation.27 We found multiple socioeconomic differences by race/ethnicity, but it is unknown whether these influenced clinical decision-making.
A significant proportion of racial/ethnic disparities in infant outcomes may be attributed to birth center.28 Racial/ethnic disparities in the quality of care and infant outcomes among preterm infants vary between centers.11,28 Our data represented a nonrandom sample of extremely preterm infants from a geographically diverse set of academic centers of excellence. Although the center was a significant confounder for overall mortality by race/ethnicity in the present study, the direction of this association indicated a trend toward lower adjusted mortality rates among minority infants across most centers.
Using a database that overcomes the limitations of vital statistics data sets,13,14 the Vermont Oxford Network found narrowing disparities in late-onset sepsis, receipt of antenatal corticosteroids, and cesarean delivery.12 Disproportionate improvements in rates of late-onset sepsis and antenatal corticosteroid receipt29 among black infants and Hispanic infants were also identified in our study, suggesting that minority infants benefitted most from quality improvement initiatives. Willingness to perform cesarean delivery is associated with improved survival,30 and narrowing disparities in cesarean delivery may reflect improved fetal monitoring. Moderate-severe neurodevelopmental impairment increased over time across all groups in our study, emphasizing the importance of long-term follow-up data. It is possible that this increase was associated with improvements in mortality because there was no significant change in the rate of death or moderate-severe neurodevelopmental impairment.
This study analyzed major outcomes, including neurodevelopmental impairment, using a large prospective database with adjustment for multiple biological, care practice, and socioeconomic variables. However, there were a number of limitations that must be noted. Race/ethnicity was recorded as reported by the mother alone, although self-reported maternal race/ethnicity and infant genetic ancestry are closely correlated.31 Furthermore, genetic ancestry markers show much heterogeneity,32 indicating that race/ethnicity may be largely a social construct.33 It is unlikely that our results are due solely to confounding, but there was likely residual bias in our models.33 For example, data were unavailable on the adequacy of prenatal care, fetal monitoring, perinatal decision-making and counseling, the length of prenatal maternal admission,30,34,35 and parental employment. The multiple testing with a 5% significance level may have resulted in outcomes being significant by chance. Our detailed data set includes a subset of infants born in academic centers in the United States that may not be representative of the broader population.
This cohort study found no racial/ethnic differences in changes in mortality rates or most major morbidities among extremely preterm infants, with mortality decreasing over time across all groups. Racial/ethnic disparities in the rate of late-onset sepsis decreased over time. There were narrowing racial/ethnic disparities in key interventions, including receipt of antenatal corticosteroids and cesarean delivery. However, there were increasing rates of moderate-severe neurodevelopmental impairment that did not differ by race/ethnicity. Adherence to evidence-based medicine and continued quality improvement efforts should further improve outcomes of extremely preterm infants among all racial and ethnic groups.
Accepted for Publication: March 30, 2020.
Published: June 10, 2020. doi:10.1001/jamanetworkopen.2020.6757
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Travers CP et al. JAMA Network Open.
Corresponding Author: Colm P. Travers, MD, Women and Infants Center, University of Alabama at Birmingham, 1700 Sixth Avenue S, 176F Ste 9380, Birmingham, AL 35249 (firstname.lastname@example.org).
Author Contributions: Mr McDonald and Dr Das had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Travers, Carlo, Ambalavanan, DeMauro, Profit, Gould, Lorch, Bidegain, Higgins.
Acquisition, analysis, or interpretation of data: Travers, McDonald, Das, Ambalavanan, Bell, Sanchez, Stoll, Wyckoff, Laptook, Van Meurs, Goldberg, D’Angio, Shankaran, DeMauro, Walsh, Peralta-Carcelen, Collins, Ball, Hale, Newman, Profit, Lorch, Bann, Higgins.
Drafting of the manuscript: Travers, Ambalavanan, Sanchez.
Critical revision of the manuscript for important intellectual content: Travers, Carlo, McDonald, Das, Bell, Sanchez, Stoll, Wyckoff, Laptook, Van Meurs, Goldberg, D’Angio, Shankaran, DeMauro, Walsh, Peralta-Carcelen, Collins, Ball, Hale, Newman, Profit, Gould, Lorch, Bann, Bidegain, Higgins.
Statistical analysis: Travers, Carlo, McDonald, Das, Bann.
Obtained funding: Travers, Bell, Sanchez, Stoll, Wyckoff, D’Angio, Shankaran, Walsh, Lorch.
Administrative, technical, or material support: Carlo, Stoll, Wyckoff, Van Meurs, D’Angio, Collins, Ball, Lorch, Higgins.
Supervision: Das, Goldberg, Shankaran, Peralta-Carcelen, Lorch, Bidegain, Higgins.
Conflict of Interest Disclosures: Dr Carlo reported receiving personal fees from Mednax outside the submitted work. Dr Das reported receiving grants from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) during the conduct of the study. Drs Ambalavanan and Bell reported receiving grants from the NIH during the conduct of the study. Dr Sanchez reported receiving grants from the NICHD Neonatal Research Network during the conduct of the study and receiving grants from Merck outside the submitted work. Drs Wyckoff, D’Angio, Shankaran, Walsh, Peralta-Carcelen, Hale, and Bann reported receiving grants from NICHD during the conduct of the study. Dr Collins reported receiving grants from the University of Alabama at Birmingham during the conduct of the study. Dr Profit reported NICHD R01 grants on disparities as submitted in manuscript 1R01HD083368-01A1 and 1R01HD084667-01A1. Dr Lorch reported receiving grants from the Agency for Healthcare and Quality during the conduct of the study. No other disclosures were reported.
Funding/Support: This study was funded by the grant RFA-HD-16-020 from the NICHD. The NICHD, the National Center for Research Resources, and the National Center for Advancing Translational Sciences provided grant support for the Neonatal Research Network’s Generic Database and Follow-up Studies through cooperative agreements.
Role of the Funder/Sponsor: The NICHD staff had input only into the study design, conduct, analysis, and manuscript drafting. No other funders had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Group Information: The following investigators, in addition to those listed as authors, participated in this study: Neonatal Research Network Steering Committee Chairs: Alan H. Jobe, MD, PhD, University of Cincinnati (2003-2006); Michael S. Caplan, MD, University of Chicago, Pritzker School of Medicine (2006-2011); and Richard A. Polin, MD, Vagelos College of Physicians and Surgeons, Division of Neonatology, Columbia University (2011-present).
Warren Alpert Medical School of Brown University and Women & Infants Hospital of Rhode Island: William Oh, MD; Martin Keszler, MD; Betty R. Vohr, MD; Robert T. Burke, MD, MPH; Bonnie E. Stephens, MD; Yvette Yatchmink, MD; Barbara Alksninis, RNC, PNP; Angelita M. Hensman, MS, RNC-NIC; Kristin Basso, RN, MaT; Elisa Vieira, RN, BSN; Carmena Bishop; Mary L. Keszler, MD; Andrea M. Knoll; Teresa M. Leach, MEd, CAES; Martha R. Leonard, BA, BS; Lucy Noel; Rachel A. Vogt, MD; and Victoria E. Watson, MS, CAS.
Case Western Reserve University, Rainbow Babies & Children's Hospital (U10 HD21364, M01 RR80): Avroy A. Fanaroff, MD; Deanne E. Wilson-Costello, MD; Bonnie S. Siner, RN; and Harriet G. Friedman, MA.
Children's Mercy Hospital, University of Missouri Kansas City School of Medicine (U10 HD68284): William E. Truog, MD; Eugenia K. Pallotto, MD, MSCE; Howard W. Kilbride MD; Cheri Gauldin, RN, BS, CCRC; Anne Holmes, RN, MSN, MBA-HCM, CCRC; Kathy Johnson, RN, CCRC; and Allison Knutson, RN, BSN.
Cincinnati Children's Hospital Medical Center, University Hospital, and Good Samaritan Hospital (U10 HD27853, UL1 TR77, M01 RR8084): Brenda B. Poindexter, MD, MS; Kurt Schibler, MD; Suhas G. Kallapur, MD; Edward F. Donovan, MD; Kate Bridges, MD; Jean J. Steichen, MD; Kimberly Yolton, PhD; Barbara Alexander, RN; Estelle E. Fischer, MHSA MBA; Cathy Grisby, BSN, CCRC; Marcia Worley Mersmann, RN; Holly L. Mincey, RN, BSN; Jody Hessling, RN; Teresa L. Gratton, PA; Lenora D. Jackson, CRC; Jennifer Jennings, RN, BSN; Kristin Kirker, CRC; Greg Muthig, BS; and Sandra Wuertz, RN, BSN, CLC.
Duke University School of Medicine, University Hospital, Duke Regional Hospital, Alamance Regional Medical Center, the University of North Carolina, and WakeMed Health & Hospitals (U10 HD40492, UL1 TR1117, M01 RR30): C. Michael Cotten, MD, MHS; Ricki F. Goldstein, MD; William F. Malcolm, MD; Patricia L. Ashley, MD; Kathy J. Auten, MSHS; Joanne Finkle, RN, JD; Kimberley A. Fisher, PhD, FNP-BC, IBCLC; Katherine A. Foy, RN; Sandra Grimes, RN, BSN; Kathryn E. Gustafson, PhD; Melody B. Lohmeyer, RN, MSN; Matthew M. Laughon, MD, MPH; Carl L. Bose, MD; Diane D. Warner, MD, MPH; Janice Bernhardt, MS, RN; Gennie Bose, RN; Janice Wereszczak, CPNP-AC/PC; Stephen D. Kicklighter, MD; and Ginger Rhodes-Ryan, ARNP MSN NNP-BC.
Emory University, Children’s Healthcare of Atlanta, Grady Memorial Hospital, and Emory University Hospital Midtown (U10 HD27851, UL1 TR454, M01 RR39): David P. Carlton, MD; Ira Adams-Chapman, MD; Ravi M. Patel, MD, MSc; Angela Leon-Hernandez, MD; Yvonne C. Loggins, RN, BSN; Diane I. Bottcher, RN, MSN; Maureen Mulligan LaRossa, RN; Sheena L. Carter, PhD; Colleen Mackie, BS, RT; and Lynn C. Wineski, NNP.
Eunice Kennedy Shriver National Institute of Child Health and Human Development: Linda L. Wright, MD; Elizabeth M. McClure, MEd; and Stephanie Wilson Archer, MA.
Indiana University, University Hospital, Methodist Hospital, Riley Hospital for Children, and Wishard Health Services (U10 HD27856, UL1 TR6, M01 RR750): Gregory M. Sokol, MD; Brenda B. Poindexter, MD, MS; James A. Lemons, MD; Heidi Harmon, MD, MS; Lu-Ann Papile, MD; Anna M. Dusick, MD (deceased); Abbey Hines, PsyD; Heike M. Minnich, PsyD HSPP; Carolyn Lytle, MD, MPH; Lon G. Bohnke, MS; Dianne E. Herron, RN; Lucy Smiley, CCRC; Susan Gunn NNP-BC, CCRC; Leslie Richard, RN; Faithe Hamer, BS; Leslie Dawn Wilson, BSN, CCRC; and Lucy C. Miller, RN, BSN, CCRC.
McGovern Medical School at The University of Texas Health Science Center at Houston, Children's Memorial Hermann Hospital, Memorial Hermann Southwest, and Lyndon Baines Johnson General Hospital/Harris County Hospital District (U10 HD21373): Kathleen A. Kennedy, MD, MPH; Jon E. Tyson, MD, MPH; Esther G. Akpa, RN, BSN; Nora I. Alaniz, BS; Julie Arldt-McAlister, MSN, APRN; Katrina Burson, RN, BSN; Pamela J. Bradt, MD, MPH; Susan E. Dieterich, PhD; Allison G. Dempsey, PhD; Andrea F. Duncan, MD; Patricia W. Evans, MD; Claudia I. Franco, RNC, MSN; Carmen Garcia, RN, BSN; Charles E. Green, PhD; Magda Cedillo Guajardo, RN, BSN, FAACM; Beverly Foley Harris, RN, BSN; Margarita Jiminez, MD, MPH; Janice John, CPNP; Patrick M. Jones, MD; M. Layne Lillie, RN, BSN; Anna E. Lis, RN, BSN; Terri L. Major-Kincade, MD, MPH; Karen Martin, RN; Sara C. Martin, RN, BSN; Georgia E. McDavid, RN; Brenda H. Morris, MD; Patricia Ann Orekoya, RN, BSN; Stacey Reddoch, BA; Shawna Rodgers, RN, BSN; Saba Khan Siddiki, MD; Maegan C. Simmons, RN; Daniel Sperry, RN; Patti L. Pierce Tate, RCP; Laura L. Whitely, MD; and Sharon L. Wright, MT, ASCP.
Nationwide Children’s Hospital and The Ohio State University Wexner Medical Center (U10 HD68278): Leif D. Nelin, MD; Sudarshan R. Jadcherla, MD; Patricia Luzader, RN; Christine A. Fortney, RN, PhD; Keith Yeates, PhD; Nehal A. Parikh, MD; Melanie Stein, BBA, RRT; Julie Gutentag, RN, BSN; Tiffany Sharp, CMDA; Courtney Cira, RRT; Lina Yossef-Salameh, MD; Pamela Morehead, BS; Cody Brennan; RoxAnn Sullivan, RN, BSN; Erin Ferns; Aubry Folwer; Jennifer Notestine, RN; Cole Hague, MS; Jennifer L. Grothause, RN; Bronte Clifford, BA; Amanda Daubenmire Morely, BS; Erin Wishloff, RRT; Sarah Keim, PhD; Helen Carey, DHSC; and Christopher Timan, MD.
RTI International (U10 HD36790): W. Kenneth Poole, PhD (deceased); Dennis Wallace, PhD; Marie G. Gantz, PhD; Jamie E. Newman, PhD, MPH; Jeanette O’Donnell Auman, BS; Margaret M. Crawford, BS, CCRP; Betty K. Hastings; Elizabeth M. McClure, PhD; Carolyn M. Petrie Huitema, MS, CCRP; and Kristin M. Zaterka-Baxter, RN, BSN, CCRP.
Stanford University, California Pacific Medical Center, Dominican Hospital, El Camino Hospital, and Lucile Packard Children's Hospital (U10 HD27880, UL1 TR93, M01 RR70): David K. Stevenson, MD; Susan R. Hintz, MD, MS Epi; Marian M. Adams, MD; Charles E. Ahlfors, MD; Joan M. Baran, PhD; Barbara Bentley, PhD; Lori E. Bond, PhD; Ginger K. Brudos, PhD; Alexis S. Davis, MD, MS; Maria Elena DeAnda, PhD; Anne M. DeBattista, PNP, PhD; Barry E. Fleisher, MD; Lynne C. Huffman, MD; Magdy Ismael, MD, MPH; Jean G. Kohn, MD, MPH; Casey Krueger, PhD; Julie C. Lee-Ancajas, PhD; Andrew W. Palmquist, RN; Melinda S. Proud, RCP; Renee P. Pyle, PhD; Dharshi Sivakumar, MD; Robert D. Stebbins, MD; Nicholas H. St John, PhD; Halie E. Weiss, MD.
Tufts Medical Center, Floating Hospital for Children (U10 HD53119, M01 RR54): Ivan D. Frantz III, MD; Elisabeth C. McGowan, MD; Brenda L. MacKinnon, RNC; Ellen Nylen, RN, BSN; Anne Furey, MPH; Ana Brussa, MS, OTR/L; and Cecelia Sibley, PT, MHA.
University of Alabama at Birmingham Health System and Children’s Hospital of Alabama (U10 HD34216, M01 RR32): Kathleen G. Nelson, MD; Kirstin J. Bailey, PhD; Fred J. Biasini, PhD; Kristy Domanovich, PhD; Shirley S. Cosby, RN, BSN; Mary Beth Moses, PT, MS, PCS; Vivien A. Phillips, RN, BSN; Julie Preskitt, MSOT, MPH; Richard V. Rector, PhD; Sally Whitley, MA, OTR-L, FAOTA; and Sheree C. York, PT, DPT, c/NDT, PCS.
University of California, Los Angeles, Mattel Children's Hospital, Santa Monica Hospital, Los Robles Hospital and Medical Center, and Olive View Medical Center (U10 HD68270): Uday Devaskar, MD; Meena Garg, MD; Isabell B. Purdy, PhD, CPNP; Teresa Chanlaw, MPH; and Rachel Geller, RN, BSN.
University of California, San Diego Medical Center and Sharp Mary Birch Hospital for Women and Newborns (U10 HD40461): Neil N. Finer, MD; Maynard R. Rasmussen MD; Yvonne E. Vaucher, MD, MPH; Paul R. Wozniak, MD; Kathy Arnell, RNC; Renee Bridge, RN; Clarence Demetrio, RN; Martha G. Fuller, RN, MSN; and Wade Rich, BSHS RRT.
University of Iowa and Mercy Medical Center (U10 HD53109, UL1 TR442, M01 RR59): Tarah T. Colaizy, MD, MPH; John A. Widness, MD; Dan L. Ellsbury, MD; Jane E. Brumbaugh, MD; Michael J. Acarregui, MD; Karen J. Johnson, RN, BSN; Jacky R. Walker, RN; Claire A. Goeke, RN; Tracy L. Tud, RN; Donia B. Campbell, RNC-NIC; and Diane L. Eastman, RN, CPNP, MA.
University of Miami, Holtz Children's Hospital (U10 HD21397, M01 RR16587): Shahnaz Duara, MD; Charles R. Bauer, MD; Ruth Everett-Thomas, RN, MSN; Amy Mur Worth, RN, MS; Mary Allison, RN; Alexis N. Diaz, BA; Elaine E. Mathews, RN; Kasey Hamlin-Smith, PhD; Lissa Jean-Gilles, BA; Maria Calejo, MS; Silvia M. Frade Eguaras, BA; Silvia Fajardo-Hiriart, MD; Yamiley C. Gideon, BA; Michelle Harwood Berkovits, PhD; Alexandra Stoerger, BA; Andrea Garcia, MA; Helena Pierre, BA; Georgette Roder, BSW; and Arielle Riguad, MD.
University of New Mexico Health Sciences Center (U10 HD27881, U10 HD53089, UL1 TR41, M01 RR997): Kristi L. Watterberg, MD; Andrea Freeman Duncan, MD, MScr; Janell Fuller, MD; Robin K. Ohls, MD; Lu-Ann Papile, MD; Conra Backstrom Lacy, RN; Sandra Brown, RN, BSN; Carol Hartenberger, BSN, MPH; Jean R. Lowe, PhD; Rebecca Montman, BSN; Tara Dupont, MD; Sandra Sundquist Beauman, MSN, RNC-NIC; and Mary Hanson, RN, BSN.
University of Pennsylvania, Hospital of the University of Pennsylvania, Pennsylvania Hospital, and Children's Hospital of Philadelphia (U10 HD68244): Barbara Schmidt, MD, MSc; Haresh Kirpalani, MB, MSc; Aasma S. Chaudhary, BS, RRT; Soraya Abbasi, MD; Toni Mancini, RN, BSN, CCRC; Dara M. Cucinotta, RN; Judy C. Bernbaum, MD; Marsha Gerdes, PhD; and Hallam Hurt, MD.
University of Rochester Medical Center, Golisano Children's Hospital, the University of Buffalo Women's, and Children's Hospital of Buffalo (U10 HD68263, U10 HD40521, UL1 TR42, M01 RR44): Dale L. Phelps, MD; Ronnie Guillet, MD, PhD; Satyan Lakshminrusimha, MD; Gary J. Myers, MD; Melissa Bowman, RN, NP; Erica Burnell, RN; Osman Farooq, MD; Stephanie Guilford, BS, CCRC; Cassandra A. Horihan, MS; Julianne Hunn, BS; Diane Hust, MS, RN, CS; Rosemary L. Jensen; Julie Babish Johnson, MSW; Emily Kushner, MA; Deanna Maffett, RN; Joan Merzbach, LMSW; Diane Prinzing; Linda J. Reubens, RN, CCRC; Ann Marie Reynolds, MD; Mary Rowan, RN; Michael G. Sacilowski, MAT, CCRC; Holly I. M. Wadkins, MA; Ashley Williams, MS Ed; Karen Wynn, NNP, RN; Kelly Yost, PhD; William Zorn, PhD; Lauren Zwetsch, RN, MS, PNP; Cait Fallone, MA; and Michelle Andrews-Hartley, MD.
University of Tennessee Health Science Center (U10 HD21415): Sheldon B. Korones, MD; Henrietta S. Bada, MD; Tina Hudson, RN, BSN; Marilyn Williams, LCSW; and Kimberly Yolton, PhD.
University of Texas Southwestern Medical Center, Parkland Health & Hospital System and Children's Medical Center Dallas (U10 HD40689, M01 RR633): Luc P. Brion, MD; Pablo J. Sánchez, MD; Abbot R. Laptook, MD; Charles R. Rosenfeld, MD; Walid A. Salhab, MD; Jon E. Tyson, MD, MPH; Myra H. Wyckoff, MD; R. Sue Broyles, MD; Roy J. Heyne, MD; Merle Ipson, MD; Sally S. Adams, MS, RN, CPNP; Cathy Twell Boatman, MS, CIMI; P. Jeannette Burchfield, RN, BSN; Lijun Chen, PhD, RN; Cristin Dooley, PhD, LSSP; Alicia Guzman; Gaynelle Hensley, RN; Elizabeth T. Heyne, MS, MA, PA-C, PsyD; Jackie F. Hickman, RN; Lizette E. Lee, RN; Melissa H. Leps, RN; Christine Lupino, MS; Linda A. Madden, BSN, RN, CPNP; Susie Madison, RN; Nancy A. Miller, RN; Janet S. Morgan, RN; Lara Pavageau, MD; and Diana M. Vasil, MSN, BSN, RNC-NIC.
University of Utah Medical Center, Intermountain Medical Center, LDS Hospital, and Primary Children's Medical Center (U10 HD53124, M01 RR64): Roger G. Faix, MD; Bradley A. Yoder, MD; Michael Steffen, MS, CPM; Shawna Baker, RN; Karie Bird, RN; Jill Burnett, RN; Jennifer J. Jensen, RN, BSN; Karen A. Osborne, RN, BSN, CCRC; Cynthia Spencer, RNC; Kimberlee Weaver-Lewis, RN, MS; Sarah Winter, MD; and Karen Zanetti, RN.
Wake Forest University Baptist Medical Center, Brenner Children's Hospital, and Forsyth Medical Center (U10 HD40498, M01 RR7122): T. Michael O’Shea, MD, MPH; Robert G. Dillard, MD; Nancy J. Peters, RN, CCRP; Korinne Chiu, MA; Deborah Evans Allred, MA, LPA; Donald J. Goldstein, PhD; Raquel Halfond, MA; Barbara G. Jackson, RN, BSN; Carroll Peterson, MA; Dia Roberts, BSN, PNP; Ellen L. Waldrep, MS; Melissa Whalen Morris, MA; Gail Wiley Hounshell, PhD; Lisa K. Washburn, MD; and Cherrie D. Welch, MD, MPH.
Wayne State University, Hutzel Women’s Hospital, and Children’s Hospital of Michigan (U10 HD21385): Beena G. Sood, MD, MS; Athina Pappas, MD; Girija Natarajan, MD; John Barks, MD; Yvette R. Johnson, MD, MPH; Sanjay Chawla, MD; Monika Bajaj, MD; Rebecca Bara, RN, BSN; Laura Goldston, MA; Eunice Woldt, RN, MSN; Mary E. Johnson, RN, BSN; Deborah Kennedy, RN, BSN; Geraldine Muran, RN, BSN; Elizabeth Billian, RN, MBA; Laura Sumner, RN, BSN; Kara Sawaya, RN, BSN; Martha Carlson, MD; Mary K. Christensen, BA, RRT; Stephanie A. Wiggins, MS; Diane White, RT; Jamie Kinrock; and Angela Argento, PhD.
Yale University, Yale-New Haven Children’s Hospital, and Bridgeport Hospital (U10 HD27871, UL1 TR142, M01 RR125, M01 RR6022): Richard A. Ehrenkranz, MD; Christine Butler, MD; Harris Jacobs, MD; Patricia Cervone, RN; Nancy Close, PhD; Patricia Gettner, RN; Walter Gilliam, PhD; Sheila Greisman, RN; Monica Konstantino, RN, BSN; JoAnn Poulsen, RN; Elaine Romano, MSN; Janet Taft, RN, BSN; and Joanne Williams, RN, BSN.
Disclaimer: The comments and views of the authors do not necessarily represent the views of NICHD, the NIH, the Department of Health and Human Services, or the US Government.
Additional Contributions: We are indebted to our medical and nursing colleagues and the infants and their parents who agreed to take part in this study.
Additional Information: Data collected at participating sites of the NICHD Neonatal Research Network were transmitted to RTI International, the data coordinating center for the network, which stored, managed, and analyzed the data for this study. Data reported in this paper may be requested through a data use agreement. Further details are available at https://neonatal.rti.org/index.cfm?fuseaction=DataRequest.Home.
Create a personal account or sign in to: